Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma. Komatsu S, Yano Y, Kido M, Kuramitsu K, et al. Anticancer Res 2022;42:5479-5486.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Komatsu S, Yano Y, Kido M, Kuramitsu K, et al. Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma. Anticancer Res 2022;42:5479-5486.
PMID: 36288850